We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
-7.3%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$310M
AUM Growth
-$58.5M
(-16%)
Cap. Flow
-$25M
Cap. Flow
% of AUM
-8.07%
Top 10 Holdings %
Top 10 Hldgs %
50.58%
Holding
85
New
10
Increased
22
Reduced
16
Closed
22
Top Buys
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$13.3M |
| 2 |
Cigna
CI
|
+$11.1M |
| 3 |
Merck
MRK
|
+$9.51M |
| 4 |
Cardinal Health
CAH
|
+$5.84M |
| 5 |
RCOR
Renovacor, Inc.
RCOR
|
+$5.23M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$8.71M |
| 2 |
Amgen
AMGN
|
+$8.53M |
| 3 |
AFMD
Affimed
AFMD
|
+$6.07M |
| 4 |
Coherus Oncology
CHRS
|
+$5.72M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$5.6M |
Sector Composition
| 1 | Healthcare | 89.14% |
| 2 | Consumer Staples | 2.95% |
| 3 | Financials | 0.57% |
| 4 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cigna
CI
$80.2B
| $27.7M | 8.92% |
138,224
+51,032
| +59% | +$11.1M |
|
2
Curis
CRIS
$9.06M
| $22.8M | 7.36% |
7,285
-1,126
| -13% | -$3.52M |
|
3
SPDR Gold Trust
GLD
$131B
| $16.8M | 5.43% |
102,553
+7,123
| +7% | +$1.19M |
|
|
SOLY
4
DELISTED
Soliton, Inc.
SOLY
| $16.8M | 5.41% |
824,803
| – | – |
|
5
Universal Health Services
UHS
$8.73B
| $14M | 4.51% |
101,051
+27,916
| +38% | +$4.23M |
|
6
HCA Healthcare
HCA
$80.7B
| $13.7M | 4.41% |
56,409
-9,164
| -14% | -$2.24M |
|
|
LKFT
7
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $11.8M | 3.81% |
+224,719
| New | +$13.3M |
|
8
Aveanna Healthcare
AVAH
$2.03B
| $11.2M | 3.61% |
1,397,272
+195,665
| +16% | +$1.9M |
|
9
Centene
CNC
$33.9B
| $11.2M | 3.6% |
179,232
+23,616
| +15% | +$1.58M |
|
10
United Therapeutics
UTHR
$22.4B
| $10.9M | 3.52% |
59,146
+12,434
| +27% | +$2.45M |
|
|
11
Merck
MRK
$298B
| $9.39M | 3.03% |
+125,000
| New | +$9.51M |
|
12
Herbalife
HLF
$1.27B
| $9.15M | 2.95% |
216,012
+61,174
| +40% | +$3.03M |
|
13
McKesson
MCK
$94.1B
| $8.73M | 2.82% |
43,797
-5,827
| -12% | -$1.16M |
|
|
14
Cardinal Health
CAH
$53.9B
| $7M | 2.26% |
141,423
+107,605
| +318% | +$5.84M |
|
|
RCOR
15
DELISTED
Renovacor, Inc.
RCOR
| $6.66M | 2.15% |
736,323
+536,323
| +268% | +$5.23M |
|
|
ALBO
16
DELISTED
Albireo Pharma Inc
ALBO
| $6.66M | 2.15% |
213,493
-52,123
| -20% | -$1.61M |
|
17
Mirum Pharmaceuticals
MIRM
$7.37B
| $4.96M | 1.6% |
248,978
-205,914
| -45% | -$3.35M |
|
18
Integer Holdings
ITGR
$3.17B
| $4.9M | 1.58% |
54,891
-11,937
| -18% | -$1.12M |
|
19
HealthEquity
HQY
$7.9B
| $4.76M | 1.53% |
73,458
+8,500
| +13% | +$590K |
|
20
Vertex Pharmaceuticals
VRTX
$121B
| $4.63M | 1.49% |
25,500
+1,600
| +7% | +$312K |
|
21
Gilead Sciences
GILD
$161B
| $4.58M | 1.47% |
+65,500
| New | +$4.6M |
|
22
Kura Oncology
KURA
$998M
| $4.28M | 1.38% |
228,318
+6,055
| +3% | +$114K |
|
23
X4 Pharmaceuticals
XFOR
$379M
| $4.26M | 1.37% |
26,820
| – | – |
|
24
Cross Country Healthcare
CCRN
$427M
| $4.24M | 1.37% |
199,460
-80,390
| -29% | -$1.51M |
|
25
Viking Therapeutics
VKTX
$4.41B
| $4.15M | 1.34% |
660,813
+41,033
| +7% | +$253K |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA